- Research Article
- 10.1093/sleep/zsaf090.0718
0718 Effects of Proximal Targeted Hypoglossal Nerve Stimulation on Apnea-Hypopnea Index in Moderate to Severe OSA: OSPREY Randomized Controlled Trial
- May 19, 2025
- SLEEP
- Atul Malhotra + 13 more +13
Abstract Introduction Clinically significant improvement of the total Apnea-hypopnea index (AHI) in the OSPREY randomized, controlled trial (RCT) of proximal hypoglossal nerve stimulation (pHGNS) was demonstrated for patients receiving active treatment compared to control at 7 months for moderate to severe obstructive sleep apnea (OSA). The AHI responses with respect to type of event, sleep stage and position during longitudinal follow-up in the preceding THN3 RCT were clinically significant and durable. Herein we report details of AHI for the OSPREY RCT. Methods OSPREY RCT participants (N=104 [Treatment=67,Control=37], no sleep endoscopy screening, AHI 15-65/hr, Body Mass Index ≤35 kg/m2) were evaluated through month 7. AHI details were compared by median values and stochastic probability of superiority (A) with bootstrapped 95% confidence intervals (95%CIs). A-values were bounded by 0 and 1, with A=1 indicating 100% likelihood of superiority and A=0.5 indicating equal likelihood (null outcome). Per convention, non-parametric effect size was characterized as large and medium for A≥0.71 and A≥0.64, respectively. Results No significant changes were observed in the Control group. AHI was decreased by pHGNS for Treatment: T=[34.3/hr to 11.6/hr, A=0.83 (95%CI:0.71-0.89)]. Similarly, Obstructive Apnea Index T=[5.2/hr to 0.6/hr, A=0.76 (95%CI:0.64-0.84)] as well as Hypopnea Index T=[23.9/hr to 9.4/hr, A=0.88 (95%CI:0.76-0.94)] were improved with pHGNS. Like improvements were observed for REM AHI T=[31.8/hr to 16.1/hr, A=0.65 (95%CI:0.52-0.75)] as well as non-REM AHI T=[34.3/hr to 10.6/hr, A=0.83 (95%CI:0.71-0.89)]. Finally, pHGNS improved Supine AHI T=[60.4/hr to 40.0/hr, A=0.63 (95%CI:0.49-0.75)] in addition to non-Supine AHI: T=[19.2/hr to 9.5/hr, A=0.65 (95%CI:0.52-0.74)]. Conclusion In the OSPREY RCT of moderate to severe OSA, pHGNS produced clinically and statistically significant reductions with medium to large effect sizes in obstructive apneas, hypopneas, and total AHI, irrespective of REM or supine position. These outcomes validate the report of long-term results from the THN3 RCT. Support (if any) LivaNova PLC
Read more